Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et...

por Song, Jinlin, Gao, Wei, Xie, Jipan, Tiwana, Simran
Publicado en Adv Ther (2019)

The Role of Health Economics and Outcomes Research in Health Care Reform in China

por Liang, Wannian, Xie, Jipan, Fu, Hongpeng, Wu, Eric Q.
Publicado 2014

Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review

por Gajria, Kavita, Lu, Mei, Sikirica, Vanja, Greven, Peter, Zhong, Yichen, Qin, Paige, Xie, Jipan
Publicado 2014

Comparative efficacy and safety of attention-deficit/hyperactivity disorder pharmacotherapies, including guanfacine extended release: a mixed treatment comparison

por Joseph, Alain, Ayyagari, Rajeev, Xie, Meng, Cai, Sean, Xie, Jipan, Huss, Michael, Sikirica, Vanja
Publicado en Eur Child Adolesc Psychiatry (2017)

A retrospective study evaluating the tolerability and effectiveness of adjunctive antihypertensive drugs in patients with inadequate response to initial treatment

por Ayyagari, Rajeev, Xie, Jipan, Cheng, David, Wu, Eric Q., Huang, Xing‐Yue, Chen, Stephanie
Publicado en J Clin Hypertens (Greenwich) (2018)

Identifying a subpopulation with higher likelihoods of early response to treatment in a heterogeneous rare disease: a post hoc study of response to teduglutide for short bowel synd...

por Chen, Kristina S, Xie, Jipan, Tang, Wenxi, Zhao, Jing, Jeppesen, Palle B, Signorovitch, James E
Publicado en Ther Clin Risk Manag (2018)

Characteristics of Patients with Psoriatic Arthritis Receiving Secukinumab and Reasons for Initiation: A US Retrospective Medical Chart Review

por Sunkureddi, Prashanth, Latremouille-Viau, Dominick, Meiselbach, Mark K., Xie, Jipan, Hur, Peter, Joshi, Reeti
Publicado en Rheumatol Ther (2019)

Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart Review

por Joshi, Reeti, Latremouille-Viau, Dominick, Meiselbach, Mark K., Xie, Jipan, Park, Yujin, Sunkureddi, Prashanth
Publicado en Drugs Real World Outcomes (2019)

The Role of Public Health in Promoting Quality Improvement in Care for Stroke and Heart Disease

por George, Mary G, Matters, Michael D, Xie, Jipan, McGruder, Henraya F, Valderrama, Amy L
Publicado 2008

Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors

por Ayyagari, Rajeev, Neary, Maureen, Li, Shang, Rokito, Ariel, Yang, Hongbo, Xie, Jipan, Benson, Al B.
Publicado en Am Health Drug Benefits (2017)

Impact of Teduglutide on Quality of Life Among Patients With Short Bowel Syndrome and Intestinal Failure

por Chen, Kristina, Mu, Fan, Xie, Jipan, Kelkar, Sneha S., Olivier, Clément, Signorovitch, James, Jeppesen, Palle B.
Publicado en JPEN J Parenter Enteral Nutr (2019)

Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity D...

por Sikirica, Vanja, Erder, M. Haim, Xie, Jipan, Macaulay, Dendy, Diener, Melissa, Hodgkins, Paul, Wu, Eric Q.
Publicado 2012

Everolimus-Based Therapy versus Chemotherapy among Patients with HR+/HER2− Metastatic Breast Cancer: Comparative Effectiveness from a Chart Review Study

por Li, Nanxin, Hao, Yanni, Xie, Jipan, Lin, Peggy L., Koo, Valerie, Ohashi, Erika, Wu, Eric Q.
Publicado en Int J Breast Cancer (2015)

Clinical outcomes among HR+/HER2− metastatic breast cancer patients with multiple metastatic sites: a chart review study in the US

por Xie, Jipan, Hao, Yanni, Li, Nanxin, Lin, Peggy L., Ohashi, Erika, Koo, Valerie, Wu, Eric Q.
Publicado en Exp Hematol Oncol (2015)

Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia

por Song, Jinlin, Ma, Qiufei, Gao, Wei, Cong, Ze, Xie, Jipan, Zimmerman, Zachary, Belton, Laura, Franklin, Janet, Palmer, Stephen
Publicado en Adv Ther (2019)

Authors’ Reply to Alatorre et al.: “Cost Effectiveness of Guanfacine Extended-Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder: Application...

por Erder, M. Haim, Xie, Jipan, Signorovitch, James E., Chen, Kristina S., Hodgkins, Paul, Lu, Mei, Wu, Eric Q., Sikirica, Vanja
Publicado 2013

Physician experiences and preferences in the treatment of HR+/HER2− metastatic breast cancer in the United States: a physician survey

por Lin, Peggy L., Hao, Yanni, Xie, Jipan, Li, Nanxin, Zhong, Yichen, Zhou, Zhou, Signorovitch, James E., Wu, Eric Q.
Publicado en Cancer Med (2015)

Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis

por Ailawadhi, Sikander, Parikh, Kejal, Abouzaid, Safiya, Zhou, Zhou, Tang, Wenxi, Clancy, Zoe, Cheung, Claudia, Zhou, Zheng-Yi, Xie, Jipan
Publicado en Blood Adv (2019)

Mid-term results and factors affecting outcome of a metal-backed unicompartmental knee design: a case series

por Seyler, Thorsten M, Mont, Michael A, Lai, Lawrence P, Xie, Jipan, Marker, David R, Zywiel, Michael G, Bonutti, Peter M
Publicado 2009

Comparative Efficacy of Guanfacine Extended Release Versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Applying Matching-...

por Sikirica, Vanja, Findling, Robert L., Signorovitch, James, Erder, M. Haim, Dammerman, Ryan, Hodgkins, Paul, Lu, Mei, Xie, Jipan, Wu, Eric Q.
Publicado 2013